INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 115 filers reported holding INTERSECT ENT INC in Q4 2015. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $5,061,000 | +17.5% | 157,397 | +3.0% | 0.00% | 0.0% |
| Q4 2018 | $4,309,000 | +97.0% | 152,885 | +100.9% | 0.00% | +100.0% |
| Q3 2018 | $2,187,000 | +26.5% | 76,088 | +64.8% | 0.00% | 0.0% |
| Q2 2018 | $1,729,000 | +39.1% | 46,173 | +46.0% | 0.00% | 0.0% |
| Q1 2018 | $1,243,000 | -10.3% | 31,634 | -28.9% | 0.00% | 0.0% |
| Q3 2017 | $1,385,000 | -8.8% | 44,478 | -18.2% | 0.00% | 0.0% |
| Q2 2017 | $1,519,000 | -48.1% | 54,350 | -64.7% | 0.00% | -50.0% |
| Q1 2016 | $2,925,000 | -5.6% | 153,934 | +11.8% | 0.00% | 0.0% |
| Q4 2015 | $3,098,000 | -62.5% | 137,700 | -61.0% | 0.00% | -60.0% |
| Q3 2015 | $8,271,000 | +92.7% | 353,466 | +135.7% | 0.01% | +150.0% |
| Q2 2015 | $4,293,000 | +99.8% | 149,951 | +80.2% | 0.00% | +100.0% |
| Q1 2015 | $2,149,000 | +94.7% | 83,205 | +39.8% | 0.00% | 0.0% |
| Q4 2014 | $1,104,000 | +86.2% | 59,536 | +55.7% | 0.00% | – |
| Q3 2014 | $593,000 | – | 38,231 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
| First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
| HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
| Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
| Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
| PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
| Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |